In Lewis Lung murine models, knock down of the TNF-α receptor (TNF-R2) in cancer cells promotes robust anti-tumour effects upon administration of low dose murine TNF-alpha, whereas in wild-type mice, it enhanced tumour growth [32]. The gene discussed is TNFRSF1B; the disease is neoplasm.